Envista Holdings Corporation (NYSE:NVST) Receives $27.69 Average Target Price from Brokerages

Envista Holdings Corporation (NYSE:NVST) has received an average recommendation of “Hold” from the sixteen research firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $27.6923.

NVST has been the subject of several analyst reports. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Evercore set a $30.00 price target on Envista in a report on Wednesday, April 8th. UBS Group raised their price target on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. Barclays boosted their price objective on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a report on Wednesday, February 11th. Finally, Leerink Partners set a $35.00 price objective on Envista and gave the company an “outperform” rating in a research report on Friday, February 6th.

Envista Stock Down 2.3%

NYSE NVST opened at $27.21 on Friday. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. Envista has a 52 week low of $14.85 and a 52 week high of $30.42. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 97.19, a PEG ratio of 1.90 and a beta of 0.98. The company has a fifty day moving average of $27.05 and a two-hundred day moving average of $23.60.

Envista (NYSE:NVST) last announced its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same period in the prior year, the company earned $0.24 EPS. The company’s revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts predict that Envista will post 1.4 earnings per share for the current year.

Insider Activity

In other news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president directly owned 32,382 shares in the company, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.99% of the company’s stock.

Institutional Investors Weigh In On Envista

Several large investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC increased its position in shares of Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after acquiring an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP boosted its holdings in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares during the period. UMB Bank n.a. grew its stake in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares in the last quarter. Finally, IFP Advisors Inc increased its holdings in Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after purchasing an additional 1,071 shares during the period.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.